Lung cancer cells rely on protein homeostasis regulators, particularly the ubiquitin-proteasome system (UPS), to sustain malignancy. Genetic alterations in UPS components, such as E3 ubiquitin ligases (E3s) and deubiquitinating enzymes (DUBs), are common and create context-dependent therapeutic dependencies. To investigate how these genetic alterations drive tumor formation, we conducted CRISPR screens on metabolically stressed murine lung cancer models and identified specific cancer dependencie
Targeting ubiquitin signaling vulnerabilities in KEAP1-inactivated lung cancer
Varun Jayeshkumar Shah·Ivan Dikic·Koraljka Husnjak·Markus E. Diefenbacher·Manuel Kaulich·Rubina Kazi·Igor Mačinković·Dmitry Namgaladze·Martin Wegner·Mathias T. Rosenfeldt·Cristian Prieto-Garcia·Bianka Bohnacker·Oliver Hartmann·Viktoria von Heyl zu Herrnsheim·Amin Wanli
